Cargando…

A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation

A new generation of anticancer therapeutics called target drugs has quickly developed in the 21(st) century. These drugs are tailored to inhibit cancer cell growth, proliferation, and viability by specific interactions with one or a few target proteins. However, despite formally known molecular targ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Artemov, Artem, Aliper, Alexander, Korzinkin, Michael, Lezhnina, Ksenia, Jellen, Leslie, Zhukov, Nikolay, Roumiantsev, Sergey, Gaifullin, Nurshat, Zhavoronkov, Alex, Borisov, Nicolas, Buzdin, Anton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745731/ https://www.ncbi.nlm.nih.gov/pubmed/26320181

Ejemplares similares

Molecular pathway activation features linked with transition from normal skin to primary and metastatic melanomas in human
por: Shepelin, Denis, et al.
Publicado: (2015)

Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathways
por: Lezhnina, Ksenia, et al.
Publicado: (2014)

Screening and personalizing nootropic drugs and cognitive modulator regimens in silico
por: Jellen, Leslie C., et al.
Publicado: (2015)

The OncoFinder algorithm for minimizing the errors introduced by the high-throughput methods of transcriptome analysis
por: Buzdin, Anton A., et al.
Publicado: (2014)

Signaling pathways activation profiles make better markers of cancer than expression of individual genes
por: Borisov, Nikolay M., et al.
Publicado: (2014)

Combinatorial high-throughput experimental and bioinformatic approach identifies molecular pathways linked with the sensitivity to anticancer target drugs
por: Venkova, Larisa, et al.
Publicado: (2015)

A role for G-CSF and GM-CSF in nonmyeloid cancers
por: Aliper, Alexander M, et al.
Publicado: (2014)

Interactome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancer
por: Aliper, Alexander M., et al.
Publicado: (2014)

In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state
por: Aliper, Alexander, et al.
Publicado: (2016)

MiRImpact, a new bioinformatic method using complete microRNA expression profiles to assess their overall influence on the activity of intracellular molecular pathways
por: Artcibasova, Alina V., et al.
Publicado: (2016)

Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells
por: Aliper, Alexander M., et al.
Publicado: (2015)

Towards natural mimetics of metformin and rapamycin
por: Aliper, Alexander, et al.
Publicado: (2017)

A systematic experimental evaluation of microRNA markers of human bladder cancer
por: Zabolotneva, Anastasia A., et al.
Publicado: (2013)

In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development
por: Ozerov, Ivan V., et al.
Publicado: (2016)

Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas
por: Petrov, Ivan, et al.
Publicado: (2017)

Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data
por: Buzdin, Anton A., et al.
Publicado: (2014)

Signaling pathway cloud regulation for in silico screening and ranking of the potential geroprotective drugs
por: Zhavoronkov, Alex, et al.
Publicado: (2014)

Characteristic patterns of microRNA expression in human bladder cancer
por: Zabolotneva, Anastasia A., et al.
Publicado: (2013)

New bioinformatic tool for quick identification of functionally relevant endogenous retroviral inserts in human genome
por: Garazha, Andrew, et al.
Publicado: (2015)

Pathway Instability Is an Effective New Mutation-Based Type of Cancer Biomarkers
por: Zolotovskaia, Marianna A., et al.
Publicado: (2019)

Pathway activation profiling reveals new insights into Age-related Macular Degeneration and provides avenues for therapeutic interventions
por: Makarev, Evgeny, et al.
Publicado: (2014)

Genetics and epigenetics of aging and longevity
por: Moskalev, Alexey A, et al.
Publicado: (2014)

Retroelement—Linked Transcription Factor Binding Patterns Point to Quickly Developing Molecular Pathways in Human Evolution
por: Nikitin, Daniil, et al.
Publicado: (2019)

Correction: Nikitin, D., et al. Retroelement—Linked Transcription Factor Binding Patterns Point to Quickly Developing Molecular Pathways in Human Evolution. Cells 2019, 8, 130
por: Nikitin, Daniil, et al.
Publicado: (2019)

Aging Chart: a community resource for rapid exploratory pathway analysis of age-related processes
por: Moskalev, Alexey, et al.
Publicado: (2016)

Machine Learning Applicability for Classification of PAD/VCD Chemotherapy Response Using 53 Multiple Myeloma RNA Sequencing Profiles
por: Borisov, Nicolas, et al.
Publicado: (2021)

Gene Expression-Based Signature Can Predict Sorafenib Response in Kidney Cancer
por: Gudkov, Alexander, et al.
Publicado: (2022)

Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients
por: Zhu, Qingsong, et al.
Publicado: (2015)

Molecular pathway activation features of pediatric acute myeloid leukemia (AML) and acute lymphoblast leukemia (ALL) cells
por: Petrov, Ivan, et al.
Publicado: (2016)

Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR Pathways
por: Kamashev, Dmitri, et al.
Publicado: (2023)

Algorithmically Reconstructed Molecular Pathways as the New Generation of Prognostic Molecular Biomarkers in Human Solid Cancers
por: Zolotovskaia, Marianna, et al.
Publicado: (2023)

RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens
por: Sorokin, Maxim, et al.
Publicado: (2020)

Deep biomarkers of human aging: Application of deep neural networks to biomarker development
por: Putin, Evgeny, et al.
Publicado: (2016)

Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs
por: Zolotovskaia, Marianna A., et al.
Publicado: (2019)

Intratumoral Heterogeneity and Longitudinal Changes in Gene Expression Predict Differential Drug Sensitivity in Newly Diagnosed and Recurrent Glioblastoma
por: Kim, Ella L., et al.
Publicado: (2020)

Use of deep neural network ensembles to identify embryonic-fetal transition markers: repression of COX7A1 in embryonic and cancer cells
por: West, Michael D., et al.
Publicado: (2017)

Atlas of RNA sequencing profiles for normal human tissues
por: Suntsova, Maria, et al.
Publicado: (2019)

New Paradigm of Machine Learning (ML) in Personalized Oncology: Data Trimming for Squeezing More Biomarkers From Clinical Datasets
por: Borisov, Nicolas, et al.
Publicado: (2019)

Transcriptomic Harmonization as the Way for Suppressing Cross-Platform Bias and Batch Effect
por: Borisov, Nicolas, et al.
Publicado: (2022)

Radioprotectors.org: an open database of known and predicted radioprotectors
por: Aliper, Alexander M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c66ghdi8l6e8psvvpogbac1u1p